SAST Senores Pharmaceuticals Ltd - 544319 - Disclosures under Reg. 31(1) and 31(2) of SEBI (SAST) Regulations, … BSE India The Exchange has received Disclosure under Regulation 31(1) and 31(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 on December 04, 2025 for Renosen Pharmaceuticals Pvt Ltd